1. Home
  2. TAK vs CBRE Comparison

TAK vs CBRE Comparison

Compare TAK & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • CBRE
  • Stock Information
  • Founded
  • TAK 1781
  • CBRE 1906
  • Country
  • TAK Japan
  • CBRE United States
  • Employees
  • TAK N/A
  • CBRE N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • CBRE Real Estate
  • Sector
  • TAK Health Care
  • CBRE Finance
  • Exchange
  • TAK Nasdaq
  • CBRE Nasdaq
  • Market Cap
  • TAK 47.3B
  • CBRE 47.3B
  • IPO Year
  • TAK N/A
  • CBRE 2004
  • Fundamental
  • Price
  • TAK $15.08
  • CBRE $165.57
  • Analyst Decision
  • TAK
  • CBRE Buy
  • Analyst Count
  • TAK 0
  • CBRE 9
  • Target Price
  • TAK N/A
  • CBRE $165.22
  • AVG Volume (30 Days)
  • TAK 3.1M
  • CBRE 1.5M
  • Earning Date
  • TAK 10-30-2025
  • CBRE 10-23-2025
  • Dividend Yield
  • TAK 3.60%
  • CBRE N/A
  • EPS Growth
  • TAK N/A
  • CBRE 19.77
  • EPS
  • TAK 0.59
  • CBRE 3.57
  • Revenue
  • TAK $31,053,301,865.00
  • CBRE $38,104,000,000.00
  • Revenue This Year
  • TAK $0.40
  • CBRE $14.30
  • Revenue Next Year
  • TAK $0.83
  • CBRE $10.11
  • P/E Ratio
  • TAK $25.50
  • CBRE $46.38
  • Revenue Growth
  • TAK 1.52
  • CBRE 14.96
  • 52 Week Low
  • TAK $12.80
  • CBRE $108.45
  • 52 Week High
  • TAK $15.69
  • CBRE $167.56
  • Technical
  • Relative Strength Index (RSI)
  • TAK 50.98
  • CBRE 62.59
  • Support Level
  • TAK $14.87
  • CBRE $161.37
  • Resistance Level
  • TAK $15.38
  • CBRE $167.56
  • Average True Range (ATR)
  • TAK 0.18
  • CBRE 2.61
  • MACD
  • TAK -0.02
  • CBRE -0.26
  • Stochastic Oscillator
  • TAK 32.97
  • CBRE 82.53

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About CBRE CBRE Group Inc

CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.

Share on Social Networks: